NIBIB Welcomes Four New Members to Advisory
Council
The National Institute of Biomedical Imaging and Bioengineering
(NIBIB) today announced the appointment of four new members to
its Advisory Council. The Council serves as the principal advisory
body to NIBIB, a component of the National Institutes of Health
within the Department of Health and Human Services (HHS). The Council,
which meets three times a year, provides recommendations on the
conduct and support of biomedical imaging and bioengineering research
and research training.
The new Advisory Council members are:
Rebecca Mary Bergman, B.S., is Vice President
of Science and Technology at Medtronic, Inc. Ms. Bergman holds
a B.S. degree in chemistry from Princeton University, and has completed
graduate studies in chemical engineering and materials science
at the University of Minnesota. She has served as an Adjunct Professor
at the University of Minnesota where she has taught courses in
biomedical engineering. Since joining Medtronic, Ms. Bergman has
been a leader in the advancement of biologically oriented sciences
in the company. She oversees Medtronic’s Materials and Biosciences
Center, the Technical Knowledge Center, innovation programs and
other corporate technology initiatives. Previously, Ms. Bergman
held scientific and research and development management positions
of increasing responsibility within Medtronic. She has received
several of the company’s highest honors, including membership in
the Bakken Society, an honorary society for Medtronic’s most distinguished
scientific and technical contributors.
Richard Lorne Ehman, M.D., is a member of the
Mayo Clinic Board of Governors and is Professor of Radiology at
the Mayo Clinic College of Medicine. Dr. Ehman has a medical degree
from the University of Saskatchewan, and did fellowships at the
University of California, San Francisco, and at the Mayo Clinic.
Dr. Ehman, who holds more than 20 patents, is known for a number
of MRI inventions which have made dramatic improvements in the
technology and have become technique mainstays adopted throughout
the industry. This includes methods for eliminating flow and motion
related image artifact, synchronizing the scan to an individual
person’s respiration pattern, and measurement of the mechanical
properties of tissue. Dr. Ehman’s current research is on nuclear
magnetic resonance phenomena, including investigation of new methods
for high resolution magnetic resonance imaging of moving structures,
techniques of ultrafast MR imaging, and methods for noninvasive
assessment of the vascular system. Dr. Ehman was awarded the Gold
Medal of the International Society of Magnetic Resonance in Medicine
(ISMRM) in 1995 for his research contributions and was elected
President of the society in 2002. He is a Fellow of the American
Institute of Medical and Biological Engineering and the American
College of Radiology. He served as a member of the Radiology and
Nuclear Medicine Study Section of the NIH from 1995-99 and returned
to serve as Chair of that study section from 2002-2004.
Katherine Whittaker Ferrara, Ph.D., is Professor
and Chair of Biomedical Engineering in the Department of Biomedical
Engineering at the University of California, Davis. Following B.S.
and M.S. degrees from California State University, Sacramento,
Dr. Ferrara received her Ph.D. in electrical engineering and computer
science from the University of California, Davis. Dr. Ferrara was
a principal member of the research staff at the Riverside Research
Institute, New York, and an Adjunct Associate Professor at Cornell
University Medical School. In addition, she was an Associate Professor
in the Department of Biomedical Engineering at the University of
Virginia, Charlottesville. Dr. Ferrara is an Associate Editor of
the IEEE Transactions on Ultrasonics, Ferroelectronics and Frequency
Control. She has conducted research and written extensively on
medical imaging and biomedical signal processing, particularly
in the areas of ultrasonics and acoustics.
David Satcher, M.D., Ph.D., former Surgeon General
of the United States and Assistant Secretary for Health at DHHS,
is currently Director of the Center of Excellence on Health Disparities
and the Poussaint-Satcher-Cosby Chair in Mental Health at Morehouse
School of Medicine. Dr. Satcher received his M.D. and Ph.D. (cytogenetics)
from Case Western Reserve University, Cleveland, Ohio. Dr. Satcher
was Director of the Centers for Disease Control and Prevention
and Administrator, Agency for Toxic Substances and Disease Registry
in Atlanta, Georgia from 1993 to 1998. Following the end of his
term as Surgeon General, he became a senior fellow at the Kaiser
Family Foundation in Washington, DC. Prior to joining DHHS, he
was President of Meharry Medical College in Nashville, Tennessee.
Dr. Satcher is a former Robert Wood Johnson Clinical Scholar and
Macy Faculty Fellow. He is the recipient of many honorary degrees
and numerous distinguished honors, including top awards from the
American Medical Association and the American College of Physicians.
Members of the Advisory Council are drawn from the scientific
communities, are appointed for 4-year terms, and represent all
areas within the Institute’s research mission.
The National Institute of Biomedical Imaging and Bioengineering
(NIBIB), a component of the National Institutes of Health, U.S.
Department of Health and Human Services, is dedicated to improving
human health through the integration of the physical and biological
sciences. The research agenda of the NIBIB seeks to dramatically
advance the Nation’s health by improving the detection, management,
understanding, and ultimately, the prevention of disease. Additional
information and publications are available at http://www.nibib.nih.gov/.
The National Institutes of Health (NIH) — The Nation's
Medical Research Agency — includes 27 Institutes and
Centers and is a component of the U.S. Department of Health and
Human Services. It is the primary federal agency for conducting
and supporting basic, clinical and translational medical research,
and it investigates the causes, treatments, and cures for both
common and rare diseases. For more information about NIH and
its programs, visit www.nih.gov. |